Severe fever with thrombocytopenia syndrome virus inhibits exogenous Type I IFN signaling pathway through its NSs invitro

PLoS One. 2017 Feb 24;12(2):e0172744. doi: 10.1371/journal.pone.0172744. eCollection 2017.

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus (SFTS virus, SFTSV). At present there is still no specific antiviral treatment for SFTSV; To understand which cells support SFTSV life cycle and whether SFTSV infection activates host innate immunity, four different cell lines (Vero, Hela, Huh7.5.1, and Huh7.0) were infected with SFTSV. Intracellular/extracellular viral RNA and expression of IFNα, and IFNß were detected by real-time RT- PCR following infection. To confirm the role of non-structural protein (NSs) of SFTSV in exogenous IFNα-induced Jak/STAT signaling, p-STAT1 (Western Blot), ISRE activity (Luciferase assay) and ISG expression (real-time PCR) were examined following IFNα stimulation in the presence or absence of over-expression of NSs in Hela cells. Our study showed that all the four cell lines supported SFTSV life cycle and SFTSV activated host innate immunity to produce type I IFNs in Hela cells but not in Huh7.0, Huh7.5.1 or Vero cells. NSs inhibited exogenous IFNα-induced Jak/STAT signaling as shown by decreased p-STAT1 level, suppressed ISRE activity and down-regulated ISG expression. Suppression of the exogenous Type I IFN-induced Jak/STAT signaling by NSs might be one of the mechanisms of SFTSV to evade host immune surveillance.

MeSH terms

  • Animals
  • Bunyaviridae Infections / genetics*
  • Bunyaviridae Infections / virology
  • Chlorocebus aethiops
  • HeLa Cells
  • Host-Parasite Interactions / genetics
  • Humans
  • Immunity, Innate / genetics
  • Interferon Type I / antagonists & inhibitors
  • Interferon Type I / genetics*
  • Phlebovirus / genetics*
  • Phlebovirus / pathogenicity
  • Signal Transduction / genetics
  • Vero Cells
  • Viral Nonstructural Proteins / genetics*

Substances

  • Interferon Type I
  • Viral Nonstructural Proteins

Grants and funding

This study was supported by Natural Science Foundation of China (NSFC, Grant No. 81400096, 81471956 and 91442128) and Funding of Scientific support, Science and Technology Department of Sichuan province (Grant No. 2014SZ0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.